サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363324

レジオネラ検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年

Legionella Testing Market Size, Share, & Trends Analysis Report By Type (Water Testing, IVD Testing), By End-use (Microbial culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
レジオネラ検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月27日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レジオネラ検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のレジオネラ検査市場規模は、2023年から2030年にかけて8.2％のCAGRを記録し、2030年までに4億9,100万米ドルに達すると予測されています。

レジオネラ関連疾患の有病率の増加は、迅速な診断手順の要求とともに、業界の成長を促進すると予測されています。

CDCによると、2013年のレジオネラ症患者数は4,548人でした。汚染された環境のため、肺炎や関連疾患の発生率は常に上昇しています。レジオネラ症の罹患率の上昇は、今後数年間、特に産業部門において市場の成長を促進すると思われます。

従来の細菌検査は労力と時間がかかるため、現在ではあまり好まれていないです。従来の微生物検査法が直面する困難に対して、迅速な自動検査が業界で人気を集めています。

レジオネラ検査市場レポートハイライト

  • 水質検査セグメントが2022年に最大の収益シェアを占めました。同分野の成長要因には、主にレジオネラ検査を義務付ける政府の法律が含まれます。
  • また、水質検査は、IVD検査に続いて予測期間中に最も急成長するセグメントと予測されています。
  • 微生物培養セグメントは、2022年に37.4%の最大の収益シェアを占めました。微生物培養は高い特異性と感度を提供し、レジオネラ菌を正確に特定します。
  • PCR分野は、予測期間中8.8%のCAGRで最も速い成長が見込まれます。PCRは、再現性のある結果とともに、タイムリーで正確な診断などの利点を提供します。したがって、細菌検査法として好まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 レジオネラ検査市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • レジオネラ検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 レジオネラ検査：タイプ別推定・動向分析

  • レジオネラ検査市場：重要なポイント
  • レジオネラ検査市場：動向と市場シェア分析、2022年および2030年
  • 水質検査
  • 体外診断検査

第5章 レジオネラ検査：最終使用別推定・動向分析

  • レジオネラ検査市場：重要なポイント
  • レジオネラ検査市場：動向と市場シェア分析、2022年および2030年
  • 微生物培養
  • 直接蛍光抗体（DFA）染色
  • PCR
  • その他（血清型別）

第6章 レジオネラ検査市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別のレジオネラ検査市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott
    • Beckman Coulter, Inc.
    • BD
    • Bio-Rad Laboratories, Inc.
    • BIOMERIEUX
    • Eiken Chemical Co., Ltd.
    • Hologic, Inc.
    • Pro Lab Diagnostics Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 France legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Denmark legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 25 Sweden legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 27 Norway legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 34 China legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 36 India legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait legionella testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Legionella testing: Market outlook
  • Fig. 9 Legionella testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Legionella testing market driver impact
  • Fig. 15 Legionella testing market restraint impact
  • Fig. 16 Legionella testing market strategic initiatives analysis
  • Fig. 17 Legionella testing market: Type movement analysis
  • Fig. 18 Legionella testing market: Type outlook and key takeaways
  • Fig. 19 Water testing market estimates and forecasts, 2018 - 2030
  • Fig. 20 IVD testing market estimates and forecasts, 2018 - 2030
  • Fig. 21 Legionella testing market: End use movement analysis
  • Fig. 22 Legionella testing market: End use outlook and key takeaways
  • Fig. 23 Microbial culture market estimates and forecasts, 2018 - 2030
  • Fig. 24 Direct fluorescent antibody (DFA) stain market estimates and forecasts, 2018 - 2030
  • Fig. 25 PCR market estimates and forecasts, 2018 - 2030
  • Fig. 26 Others (serotyping) market estimates and forecasts, 2018 - 2030
  • Fig. 27 Global legionella testing market: Regional movement analysis
  • Fig. 28 Global legionella testing market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-372-0

Legionella Testing Market Growth & Trends:

The global legionella testing market size is expected to reach USD 491.0 million by 2030, registering a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected to drive the industry growth.

According to the CDC, the number of people suffering from Legionnaires' disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due to the contaminated environment. The rising incidence of Legionellosis will drive market growth in the coming years, especially in the industrial sector.

The conventional bacterial testing is least preferred nowadays since it is labor-intensive and time-consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry.

Legionella Testing Market Report Highlights:

  • The water testing segment held the largest revenue share in 2022. The factors contributing to the segment growth mainly include government laws that mandate the testing for Legionella
  • Water testing has also been projected as the fastest-growing segment over the forecast period followed by IVD testing
  • The microbial culture segment accounted for the largest revenue share of 37.4% in 2022. Microbial culture offers high specificity and sensitivity, accurately identifying Legionella bacteria.
  • The PCR segment is expected to grow at the fastest CAGR of 8.8% during the forecast period. PCR provides benefits such as timely and accurate diagnosis along with reproducible results. Hence, it is preferred as a bacterial testing method.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Legionella Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Legionella Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Legionella Testing: Type Estimates & Trend Analysis

  • 4.1. Legionella Testing Market: Key Takeaways
  • 4.2. Legionella Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Water Testing
    • 4.3.1. Water testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. IVD Testing
    • 4.4.1. IVD testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Legionella Testing: End Use Estimates & Trend Analysis

  • 5.1. Legionella Testing Market: Key Takeaways
  • 5.2. Legionella Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Microbial Culture
    • 5.3.1. Microbial culture market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Direct Fluorescent Antibody (DFA) Stain
    • 5.4.1. Direct fluorescent antibody (DFA) stain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. PCR
    • 5.5.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others (serotyping)
    • 5.6.1. Others (serotyping) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Legionella Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Legionella Testing Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Beckman Coulter, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. BD
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bio-Rad Laboratories, Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BIOMERIEUX
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Eiken Chemical Co., Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Hologic, Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Pro Lab Diagnostics Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. QIAGEN
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. F. Hoffmann-La Roche Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Takara Bio Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Thermo Fisher Scientific Inc.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives